Table 1.
Incidence of symptomatic thromboembolic events by type of surgery and anesthesia
| Type of anesthesia | Hip surgery
|
Knee surgery
|
||||
|---|---|---|---|---|---|---|
| Rivaroxaban | SOC | Total | Rivaroxaban | SOC | Total | |
| All, % (n/N) | 0.6 (28/4,688) | 1.2 (55/4,637) | 0.9 (83/9,325) | 1.2 (50/4,052) | 1.6 (62/3,950) | 1.4 (112/8,002) |
| General, % (n/N) | 0.9 (19/2,026) | 1.2 (24/1,940) | 1.1 (43/3,966) | 1.7 (20/1,194) | 2.5 (29/1,164) | 2.1 (49/2,358) |
| Neuraxial, % (n/N) | 0.3 (8/2,550) | 1.0 (27/2,596) | 0.7 (35/5,146) | 0.9 (23/2,622) | 1.1 (28/2,557) | 1.0 (51/5,179) |
Note: Results are presented for the safety population (patients who received at least one dose of rivaroxaban or SOC).
Abbreviation: SOC, standard of care.